Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2010-A01382-37 | Other Identifier | Afssaps |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Ministry of Health, France | OTHER_GOV |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Multicenter open-label prospective comparative study of PET-scan and MRI at the time of diagnosis, after 3 cycles of induction therapy (RVD) and at the completion of therapy.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| PET scan | Procedure | Performed at diagnosis, after 3 cycles of induction therapy, and at completion of therapy | ||
| MRI | Procedure | Performed at diagnosis, after 3 cycles of induction therapy, and at completion of therapy |
| Measure | Description | Time Frame |
|---|---|---|
| Number of patients with at least one lesion not detected on the MRI lesions | At diagnosis |
| Measure | Description | Time Frame |
|---|---|---|
| Negativity of the exam after 3 cycles of chemotherapy and just before the maintenance treatment | 3 months and 7 months | |
| Number of lesions at diagnosis | Inclusion (diagnosis) | |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Bordeaux University Hospital | Bordeaux | France | ||||
| Brest University Hospital "CHU du Morvan" |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 33151787 | Derived | Zamagni E, Nanni C, Dozza L, Carlier T, Bailly C, Tacchetti P, Versari A, Chauvie S, Gallamini A, Gamberi B, Caillot D, Patriarca F, Macro M, Boccadoro M, Garderet L, Barbato S, Fanti S, Perrot A, Gay F, Sonneveld P, Karlin L, Cavo M, Bodet-Milin C, Moreau P, Kraeber-Bodere F. Standardization of 18F-FDG-PET/CT According to Deauville Criteria for Metabolic Complete Response Definition in Newly Diagnosed Multiple Myeloma. J Clin Oncol. 2021 Jan 10;39(2):116-125. doi: 10.1200/JCO.20.00386. Epub 2020 Nov 5. | |
| 33006656 |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009101 | Multiple Myeloma |
| ID | Term |
|---|---|
| D054219 | Neoplasms, Plasma Cell |
| D009370 | Neoplasms by Histologic Type |
| D009369 | Neoplasms |
| D020141 | Hemostatic Disorders |
Not provided
Not provided
| ID | Term |
|---|---|
| D009682 | Magnetic Resonance Spectroscopy |
| ID | Term |
|---|---|
| D013057 | Spectrum Analysis |
| D002623 | Chemistry Techniques, Analytical |
| D008919 | Investigative Techniques |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| diffuse disease at diagnosis |
| Diagnosis time (inclusion) |
| Direct costs of PET and MRI at diagnosis, after the first cycles of chemotherapy and before the maintenance treatment | Inclusion, 3 months and 7 months |
| Brest |
| France |
| Hospital "Côte de Nacre" | Caen | France |
| Clermont-Ferrand University Hospital | Clermont-Ferrand | France |
| Dijon University Hospital | Dijon | France |
| Grenoble University Hospital "Hôpital Michallon" | Grenoble | France |
| Le Mans Hospital | Le Mans | France |
| Lille University Hospital "Claude Huriez" | Lille | France |
| Lyon University Hospital | Lyon | France |
| "Institut Paoli Calmettes" | Marseille | France |
| Metz University Hospital "Hôpital de Mercy" | Metz | France |
| Nancy University Hospita "Hôpitaux de Brabois" | Nancy | France |
| Nantes University Hospital | Nantes | 44000 | France |
| APHP "Hôpital Saint-Antoine" | Paris | France |
| Rennes University Hospital | Rennes | France |
| Toulouse University Hospital | Toulouse | France |
| Tours University Hospital "Hôpital Bretonneau" | Tours | France |
| Derived |
| Jamet B, Morvan L, Nanni C, Michaud AV, Bailly C, Chauvie S, Moreau P, Touzeau C, Zamagni E, Bodet-Milin C, Kraeber-Bodere F, Mateus D, Carlier T. Random survival forest to predict transplant-eligible newly diagnosed multiple myeloma outcome including FDG-PET radiomics: a combined analysis of two independent prospective European trials. Eur J Nucl Med Mol Imaging. 2021 Apr;48(4):1005-1015. doi: 10.1007/s00259-020-05049-6. Epub 2020 Oct 2. |
| D014652 |
| Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D010265 | Paraproteinemias |
| D001796 | Blood Protein Disorders |
| D006402 | Hematologic Diseases |
| D006425 | Hemic and Lymphatic Diseases |
| D006474 | Hemorrhagic Disorders |
| D008232 | Lymphoproliferative Disorders |
| D007160 | Immunoproliferative Disorders |
| D007154 | Immune System Diseases |